Cell cycle arrest and antitumor activity of pironetin and its derivatives

Cancer Letters

Volumn 126, Issue 1, 1998, Pages 29-32

  Kondoh, Masuo ^a,b   Usui, Takeo ^a   Kobayashi, Shinichi ^c   Tsuchiya, Kouichi ^c   Nishikawa, Kiyohiro ^c   Nishikiori, Takaaki ^c   Mayumi, Tadanori ^b   Osada, Hiroyuki ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NIPPON KAYAKU CO LTD   (Japan)

Author keywords

M phase inhibitor; P388 leukemia; Pironetin

Indexed keywords

ANTINEOPLASTIC AGENT; NK 10958P; PIRONETIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA P 388; METAPHASE; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DIVISION; DEMECOLCINE; HUMANS; MICE; PYRONES; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0344653657     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00528-4     Document Type: Article

References (14)

1. Correia J.J. Effects of antimitotic agents on tubulin-nucleotide interaction. Pharmacol. Ther. 52:1991;127-147.
2. Kobayashi S., Tsuchiya K., Harada T., Nishide M., Kurokawa T., Nakagawa T., Shimada N. Pironetin, a novel plant growth regulator produced by Streptomyces sp. NK10958 I. Taxonomy, production, isolation and preliminary characterization. J. Antibiot. 47:1994;697-702.
3. Kobayashi S., Tsuchiya K., Kurokawa T., Nakagawa T., Shimada N. Pironetin, a novel plant growth regulator produced by Streptomyces sp. NK10958. II. Structural elucidation. J. Antibiot. 47:1994;703-707.
4. Yasui K., Tamura Y., Nakatani T., Horibe I., Kawada K., Koizumi K., Suzuki R., Ohtani M. Chemical modification of PA-48153C, a novel immunosuppressant isolated from Streptomyces prunicolor PA-48153. J. Antibiot. 49:1996;173-180.
5. Tsuchiya K., Kobayashi S., Nishikiori T., Nakagawa T., Tatsuta K. NK10958P, a novel plant growth regulator produced by Streptomyces sp. J. Antibiot. 50:1997;259-260.
6. Kimura G., Itagaki A., Summers J. Rat cell line 3Y1 and its virogenic polyoma- and SV40-transformed derivatives. Int. J. Cancer. 15:1975;694-706.
7. Gey G.O., Coffman W.D., Kubicek G.D. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12:1952;264-265.
8. Eva A., Robbins K.C., Andersen P.R., Srinivasan A., Tronick S.R., Reddy E.P., Ellmore N.W., Galen A.T., Lautenberger J.A., Papas T.S., Westin E.H., Wong-Staal F., Gallo R.C., Aaronson S.A. Cellular genes analogous to retroviral oncogenes are transcribed in human tumour cells. Nature. 295:1982;116-119.
9. Yang S.S., Chan C., Thompson E.B. Rescue of a rat tropic rat hepatoma virus pseudotype Kirsten sarcomavirus by co-cultivation of hepatoma tissue culture cells with K-NRK cells. J. Gen. Virol. 31:1976;239-243.
10. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application of proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
11. Puchtler H., Waldrop F.S., Meloan S.N., Terry M.S., Conner H.M. Methacarn (methanol-Carnoy) fixation. Practical and theoretical considerations. Histochemie. 21:1970;97-116.
12. Geran R.I., Greenberg N.H., MacDonald M.M., Schmacher A.M., Abbot B.J. Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother. Rep. 3(Part 3):1972;1-103.
13. Schindler R. Structure-activity relationships in a series of colchicine analogs. J. Pharmacol. Exp. Ther. 149:1965;409-416.
14. Takahashi M., Iwasaki S., Kobayashi H., Okuda S., Murai T., Sato Y., Haraguchi-Hiraoka T., Nagano H. Studies on macrocyclic lactone antibiotics. XI. Anti-mitotic and anti-tubulinactivity of new antitumor antibiotics, rhizoxin and its homologues. J. Antibiot. 40:1987;66-72.